Recent studies have demonstrated that pain is partially regulated by the gut microbiota. However, the association of gut microbiota with painful diabetic neuropathy, a common complication of diabetes, remains unclear. Herein, we investigated whether the gut microbiota is associated with mechanical allodynia during the early stage of hyperglycemia in 7-week-old db/db mice. The db/db mice were intraperitoneally injected with metformin for 2 weeks. Using the von Frey test and gut microbiota analyses, we investigated the association of gut microbial changes with mechanical allodynia in 7-week-old mice. In db/db mice, colonic microbial community profiles were altered, and both unweighted and weighted UniFrac distances were reduced. Colonic genus-level abundances of Alloprevotella and Prevotellaceae_UCG-001 were positively correlated with mechanical allodynia in db/db mice, while the abundance of Odoribacter was negatively correlated. Intraperitoneal injection of metformin for 2 weeks alleviated mechanical allodynia in db/db mice but did not achieve an anti-diabetic effect. Metformin altered colonic microbial communities and increased weighted UniFrac distance in db/db mice, although its analgesic effect was not associated with specific bacteria. Additionally, alteration of small intestinal microbial community profiles and reduction in weighted UniFrac distance were observed in db/db mice, which were not affected by metformin. These results provide potential evidence of the association of the gut microbiota with mechanical allodynia during early-stage of hyperglycemia.
Published in | International Journal of Diabetes and Endocrinology (Volume 6, Issue 4) |
DOI | 10.11648/j.ijde.20210604.15 |
Page(s) | 150-159 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Gut Microbiota, Painful Diabetic Neuropathy, Mechanical Allodynia, Metformin
[1] | Santoni, M., F. Miccini, and N. Battelli. (2021). Gut microbiota, immunity and pain. Immunol Lett, 229: p. 44-47. |
[2] | Guo, R., L. H. Chen, C. Xing, and T. Liu. (2019). Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential. Br J Anaesth, 123 (5): p. 637-654. |
[3] | Luczynski, P., M. Tramullas, M. Viola, F. Shanahan, G. Clarke, S. O'Mahony, et al. (2017). Microbiota regulates visceral pain in the mouse. Elife, 6. |
[4] | O'Mahony, S. M., V. D. Felice, K. Nally, H. M. Savignac, M. J. Claesson, P. Scully, et al. (2014). Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience, 277: p. 885-901. |
[5] | Verdu, E. F., P. Bercik, M. Verma-Gandhu, X. X. Huang, P. Blennerhassett, W. Jackson, et al. (2006). Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut, 55 (2): p. 182-90. |
[6] | Shen, S., G. Lim, Z. You, W. Ding, P. Huang, C. Ran, et al. (2017). Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat Neurosci, 20 (9): p. 1213-1216. |
[7] | Amaral, F. A., D. Sachs, V. V. Costa, C. T. Fagundes, D. Cisalpino, T. M. Cunha, et al. (2008). Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A, 105 (6): p. 2193-7. |
[8] | Yang, C., X. Fang, G. Zhan, N. Huang, S. Li, J. Bi, et al. (2019). Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain. Transl Psychiatry, 9 (1): p. 57. |
[9] | Guastella, V. and G. Mick. (2009). Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy. Diabetes Metab, 35 (1): p. 12-9. |
[10] | Boulton, A. J., R. A. Malik, J. C. Arezzo, and J. M. Sosenko. (2004). Diabetic somatic neuropathies. Diabetes Care, 27 (6): p. 1458-86. |
[11] | Malik, R. A. (2020). Diabetic neuropathy: A focus on small fibres. Diabetes Metab Res Rev, 36 Suppl 1: p. e3255. |
[12] | Scholz, J., J. P. Rathmell, W. S. David, D. A. Chad, A. C. Broderick, S. G. Perros, et al. (2016). A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathy. Pain, 157 (10): p. 2297-2308. |
[13] | Wang, S., K. Kobayashi, Y. Kogure, H. Yamanaka, S. Yamamoto, H. Yagi, et al. (2018). Negative Regulation of TRPA1 by AMPK in Primary Sensory Neurons as a Potential Mechanism of Painful Diabetic Neuropathy. Diabetes, 67 (1): p. 98-109. |
[14] | Iqbal, Z., S. Azmi, R. Yadav, M. Ferdousi, M. Kumar, D. J. Cuthbertson, et al. (2018). Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Clin Ther, 40 (6): p. 828-849. |
[15] | Vallianou, N. G., T. Stratigou, and S. Tsagarakis. (2019). Metformin and gut microbiota: their interactions and their impact on diabetes. Hormones (Athens), 18 (2): p. 141-144. |
[16] | Forslund, K., F. Hildebrand, T. Nielsen, G. Falony, E. Le Chatelier, S. Sunagawa, et al. (2015). Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature, 528 (7581): p. 262-266. |
[17] | Gurung, M., Z. Li, H. You, R. Rodrigues, D. B. Jump, A. Morgun, et al. (2020). Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine, 51: p. 102590. |
[18] | Wu, H., E. Esteve, V. Tremaroli, M. T. Khan, R. Caesar, L. Mannerås-Holm, et al. (2017). Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med, 23 (7): p. 850-858. |
[19] | Fugmann, M., M. Breier, M. Rottenkolber, F. Banning, U. Ferrari, V. Sacco, et al. (2015). The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes. Sci Rep, 5: p. 13212. |
[20] | Yuan, Y., J. Zhou, Y. Zheng, Z. Xu, Y. Li, S. Zhou, et al. (2020). Beneficial effects of polysaccharide-rich extracts from Apocynum venetum leaves on hypoglycemic and gut microbiota in type 2 diabetic mice. Biomed Pharmacother, 127: p. 110182. |
[21] | Kang, Y., Y. Li, Y. Du, L. Guo, M. Chen, X. Huang, et al. (2019). Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota. Int J Obes (Lond), 43 (8): p. 1631-1643. |
[22] | Wei, S., R. Han, J. Zhao, S. Wang, M. Huang, Y. Wang, et al. (2018). Intermittent administration of a fasting-mimicking diet intervenes in diabetes progression, restores beta cells and reconstructs gut microbiota in mice. Nutr Metab (Lond), 15: p. 80. |
[23] | Li, H., F. Liu, J. Lu, J. Shi, J. Guan, F. Yan, et al. (2020). Probiotic Mixture of Lactobacillus plantarum Strains Improves Lipid Metabolism and Gut Microbiota Structure in High Fat Diet-Fed Mice. Front Microbiol, 11: p. 512. |
[24] | Duan, C., L. Kuang, X. Xiang, J. Zhang, Y. Zhu, Y. Wu, et al. (2020). Activated Drp1-mediated mitochondrial ROS influence the gut microbiome and intestinal barrier after hemorrhagic shock. Aging (Albany NY), 12 (2): p. 1397-1416. |
[25] | Song, X., L. Zhong, N. Lyu, F. Liu, B. Li, Y. Hao, et al. (2019). Inulin Can Alleviate Metabolism Disorders in ob/ob Mice by Partially Restoring Leptin-related Pathways Mediated by Gut Microbiota. Genomics Proteomics Bioinformatics, 17 (1): p. 64-75. |
[26] | Lin, B., Y. Wang, P. Zhang, Y. Yuan, Y. Zhang, and G. Chen. (2020). Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy. J Headache Pain, 21 (1): p. 103. |
[27] | Zhou, F., X. Wang, B. Han, X. Tang, R. Liu, Q. Ji, et al. (2021). Short-chain fatty acids contribute to neuropathic pain via regulating microglia activation and polarization. Mol Pain, 17: p. 1744806921996520. |
[28] | Wang, S., S. Qi, Y. Kogure, H. Kanda, L. Tian, S. Yamamoto, et al. (2020). The ubiquitin E3 ligase Nedd 4-2 relieves mechanical allodynia through the ubiquitination of TRPA1 channel in db/db mice. Eur J Neurosci. |
[29] | Tseng, C. H. (2018). Metformin and Helicobacter pylori Infection in Patients With Type 2 Diabetes. Diabetes Care, 41 (4): p. e42-e43. |
[30] | Shin, N. R., J. C. Lee, H. Y. Lee, M. S. Kim, T. W. Whon, M. S. Lee, et al. (2014). An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut, 63 (5): p. 727-35. |
[31] | Silamiķele, L., I. Silamiķelis, M. Ustinova, Z. Kalniņa, I. Elbere, R. Petrovska, et al. (2021). Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes. Frontiers in Endocrinology, 12 (231). |
[32] | Hannachi, N. and L. Camoin-Jau. (2021). Drug Response Diversity: A Hidden Bacterium? J Pers Med, 11 (5). |
[33] | Schalliol, L. A. and J. M. Pittman, Chapter 35 - Insulin and other hypoglycemic drugs, in Side Effects of Drugs Annual, S. D. Ray, Editor. 2020, Elsevier. p. 441-448. |
[34] | Lee, H., Y. Lee, J. Kim, J. An, S. Lee, H. Kong, et al. (2018). Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice. Gut Microbes, 9 (2): p. 155-165. |
[35] | Zhang, X., Y. Zhao, J. Xu, Z. Xue, M. Zhang, X. Pang, et al. (2015). Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Scientific Reports, 5 (1): p. 14405. |
[36] | Louis, S., R. M. Tappu, A. Damms-Machado, D. H. Huson, and S. C. Bischoff. (2016). Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing. PLoS One, 11 (2): p. e0149564. |
[37] | Dong, T. S., H. H. Chang, M. Hauer, V. Lagishetty, W. Katzka, E. Rozengurt, et al. (2019). Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity. Am J Physiol Gastrointest Liver Physiol, 317 (6): p. G763-g772. |
[38] | Duca, F. A., T. M. Z. Waise, W. T. Peppler, and T. K. T. Lam. (2021). The metabolic impact of small intestinal nutrient sensing. Nat Commun, 12 (1): p. 903. |
[39] | Bauer, P. V., F. A. Duca, T. M. Z. Waise, B. A. Rasmussen, M. A. Abraham, H. J. Dranse, et al. (2018). Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway. Cell Metab, 27 (1): p. 101-117. e5. |
APA Style
Xinting Wang, Jihong Wu, Simin Qi, Rui Huang, Xiaoping Wu, et al. (2021). Early-stage Hyperglycemia-induced Gut Microbial Changes Are Partially Associated with Mechanical Allodynia in db/db Mice. International Journal of Diabetes and Endocrinology, 6(4), 150-159. https://doi.org/10.11648/j.ijde.20210604.15
ACS Style
Xinting Wang; Jihong Wu; Simin Qi; Rui Huang; Xiaoping Wu, et al. Early-stage Hyperglycemia-induced Gut Microbial Changes Are Partially Associated with Mechanical Allodynia in db/db Mice. Int. J. Diabetes Endocrinol. 2021, 6(4), 150-159. doi: 10.11648/j.ijde.20210604.15
AMA Style
Xinting Wang, Jihong Wu, Simin Qi, Rui Huang, Xiaoping Wu, et al. Early-stage Hyperglycemia-induced Gut Microbial Changes Are Partially Associated with Mechanical Allodynia in db/db Mice. Int J Diabetes Endocrinol. 2021;6(4):150-159. doi: 10.11648/j.ijde.20210604.15
@article{10.11648/j.ijde.20210604.15, author = {Xinting Wang and Jihong Wu and Simin Qi and Rui Huang and Xiaoping Wu and Lin Tian and Peili Wang and Shenglan Wang}, title = {Early-stage Hyperglycemia-induced Gut Microbial Changes Are Partially Associated with Mechanical Allodynia in db/db Mice}, journal = {International Journal of Diabetes and Endocrinology}, volume = {6}, number = {4}, pages = {150-159}, doi = {10.11648/j.ijde.20210604.15}, url = {https://doi.org/10.11648/j.ijde.20210604.15}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20210604.15}, abstract = {Recent studies have demonstrated that pain is partially regulated by the gut microbiota. However, the association of gut microbiota with painful diabetic neuropathy, a common complication of diabetes, remains unclear. Herein, we investigated whether the gut microbiota is associated with mechanical allodynia during the early stage of hyperglycemia in 7-week-old db/db mice. The db/db mice were intraperitoneally injected with metformin for 2 weeks. Using the von Frey test and gut microbiota analyses, we investigated the association of gut microbial changes with mechanical allodynia in 7-week-old mice. In db/db mice, colonic microbial community profiles were altered, and both unweighted and weighted UniFrac distances were reduced. Colonic genus-level abundances of Alloprevotella and Prevotellaceae_UCG-001 were positively correlated with mechanical allodynia in db/db mice, while the abundance of Odoribacter was negatively correlated. Intraperitoneal injection of metformin for 2 weeks alleviated mechanical allodynia in db/db mice but did not achieve an anti-diabetic effect. Metformin altered colonic microbial communities and increased weighted UniFrac distance in db/db mice, although its analgesic effect was not associated with specific bacteria. Additionally, alteration of small intestinal microbial community profiles and reduction in weighted UniFrac distance were observed in db/db mice, which were not affected by metformin. These results provide potential evidence of the association of the gut microbiota with mechanical allodynia during early-stage of hyperglycemia.}, year = {2021} }
TY - JOUR T1 - Early-stage Hyperglycemia-induced Gut Microbial Changes Are Partially Associated with Mechanical Allodynia in db/db Mice AU - Xinting Wang AU - Jihong Wu AU - Simin Qi AU - Rui Huang AU - Xiaoping Wu AU - Lin Tian AU - Peili Wang AU - Shenglan Wang Y1 - 2021/12/02 PY - 2021 N1 - https://doi.org/10.11648/j.ijde.20210604.15 DO - 10.11648/j.ijde.20210604.15 T2 - International Journal of Diabetes and Endocrinology JF - International Journal of Diabetes and Endocrinology JO - International Journal of Diabetes and Endocrinology SP - 150 EP - 159 PB - Science Publishing Group SN - 2640-1371 UR - https://doi.org/10.11648/j.ijde.20210604.15 AB - Recent studies have demonstrated that pain is partially regulated by the gut microbiota. However, the association of gut microbiota with painful diabetic neuropathy, a common complication of diabetes, remains unclear. Herein, we investigated whether the gut microbiota is associated with mechanical allodynia during the early stage of hyperglycemia in 7-week-old db/db mice. The db/db mice were intraperitoneally injected with metformin for 2 weeks. Using the von Frey test and gut microbiota analyses, we investigated the association of gut microbial changes with mechanical allodynia in 7-week-old mice. In db/db mice, colonic microbial community profiles were altered, and both unweighted and weighted UniFrac distances were reduced. Colonic genus-level abundances of Alloprevotella and Prevotellaceae_UCG-001 were positively correlated with mechanical allodynia in db/db mice, while the abundance of Odoribacter was negatively correlated. Intraperitoneal injection of metformin for 2 weeks alleviated mechanical allodynia in db/db mice but did not achieve an anti-diabetic effect. Metformin altered colonic microbial communities and increased weighted UniFrac distance in db/db mice, although its analgesic effect was not associated with specific bacteria. Additionally, alteration of small intestinal microbial community profiles and reduction in weighted UniFrac distance were observed in db/db mice, which were not affected by metformin. These results provide potential evidence of the association of the gut microbiota with mechanical allodynia during early-stage of hyperglycemia. VL - 6 IS - 4 ER -